Surgical Innovations receives US approval

SURGICAL Innovations has received permission to launch its groundbreaking LogiFlex device in the US, the world's biggest market for surgery on obese patients.

The Leeds-based group , which designs and manufactures innovative medical devices, received clearance from the US Food and Drug Administration for LogiFlex, which uses pioneering technology to help surgeons fit gastric bands on obese patients.

LogiFlex was launched in the UK last year and was well received by surgeons at the World Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) as an "innovative cost effective solution" due to its reusable elements.

Hide Ad
Hide Ad

The firm said it is estimated that 250,000 anti-obesity procedures are performed annually in the US where obesity affects more than 60m people, representing the second largest cause of preventable death.

Chief executive Graham Bowland said: "We are delighted to be able to announce this approval which will see the pioneering device now being sold into the US. The majority of surgical instruments in the US are single use; however with growing financial constraints being placed on hospital budgets, procurement managers are continuously looking for cost effective instrumentation and LogiFlex offers the ideal high quality, cost effective solution."

Related topics: